Compare STIM & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | LODE |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 127.0M |
| IPO Year | 2018 | 2004 |
| Metric | STIM | LODE |
|---|---|---|
| Price | $1.26 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.25 | ★ 63.55 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $52,776,000.00 | $1,553,796.00 |
| Revenue This Year | $8.63 | $303.79 |
| Revenue Next Year | $9.24 | $410.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.80 | $1.31 |
| 52 Week High | $3.44 | $4.98 |
| Indicator | STIM | LODE |
|---|---|---|
| Relative Strength Index (RSI) | 29.12 | 31.93 |
| Support Level | $1.13 | $1.31 |
| Resistance Level | $1.61 | $3.61 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 4.59 | 1.92 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.